A peptide Certificate of Analysis, or COA, is most useful when it can be connected to the material a laboratory actually receives. For UK research procurement, our starting question is simple: what does this document establish about this sample, and what is still unknown?

At a glance

  • Match the document to the specific product and lot.
  • Read the test method alongside the result.
  • Check any accreditation claim against its relevant scope.

Start with the product and batch

Our document-review checklist begins with the product identifier, sample or lot reference, testing organisation and report date. Compare them with the supplier listing and, on receipt, the vial or package label. A mismatch is a request for clarification; a familiar logo does not resolve it.

Keep the original report rather than a cropped screenshot. Record where it came from and when you checked it. If the laboratory offers a verification service, use its own website or contact details to confirm the report reference. These are procurement checks we recommend, not a claim that every laboratory uses the same document format.

Read methods and results together

NIBSC’s peptide-library record lists HPLC, mass spectrometry and sequence information as distinct material data. That separation is useful: a purity measurement and an identity-related measurement do not answer the same question. Ask the supplier what each reported method establishes for the sample.

Avoid treating a percentage as a complete account of the vial. Ask what the percentage measures, how the stated content was assigned, and which other attributes were tested. A report can be useful without answering every question; the important point is to make its scope visible.

Sources: [1]

Check the scope of an accreditation claim

UKAS explains that a fixed accreditation scope defines the activities for which a testing or calibration laboratory has demonstrated competence. If a supplier presents a laboratory’s accreditation as supporting a particular result, check the applicable schedule and method rather than relying on a badge alone.

Accreditation of an activity, a report-verification reference and approval of a finished medicine are separate matters. The label on a supplier page should make clear which of those is being claimed.

Sources: [2]

A practical review sheet

CheckWhat to recordIf unclear
Product and lotExact identifiers on the listing, report and received labelRequest the batch association
Analytical resultMethod, units and reported outcomeAsk what the value represents
Report provenanceOriginal file, laboratory and verification referenceContact the issuing laboratory
ScopeTests covered and any applicable accreditation scheduleRequest the relevant scope
DecisionReviewer, date and unresolved questionsKeep approval pending

Using the Selective Peptides report tree

Our Purity reports section separates supplier-linked documents, verification references and missing-report requests. Some entries carry review notes. A document link is therefore a starting point for assessment, not a promise that a future supplied batch has been approved.

Use the tree to identify what to request, then retain the supplier’s answer with your own procurement record. That creates a clearer paper trail than ranking suppliers by a purity headline alone.

Questions answered

Does a high HPLC percentage prove a product is suitable for every experiment?

No. Suitability depends on the experiment and the attributes measured. Ask which tests are relevant to your laboratory’s requirements.

Does a COA make a research product a licensed medicine?

No. Analytical documentation and medicinal-product status are different questions. UK classification should be checked against current MHRA guidance.

Sources & further reading

Source record assembled for this editorial on 25 October 2026. Research dates are shown separately from our publication date. Live trial status and supplier information may change.

  1. Peptide library: material data and storage ↗NIBSC / MHRA
  2. UKAS policy on fixed and flexible scopes ↗United Kingdom Accreditation Service
  3. Medicinal-product classification guidance ↗MHRA · Updated 2 July 2026

Independent, source-based editorial. No clinical review or affiliation with the cited research institutions is claimed.

Read our editorial approach ↗
Open the purity report tree ↗